Company page

Polaryx Therapeutics, Inc.

Polaryx Therapeutics, Inc. (ticker: PLYX) is a public company operating in the American market with a market capitalization of approximately $109.8 million. The company focuses on developing innovative therapies to address unmet medical needs. Polaryx is committed to advancing its pipeline and contributing to the healthcare sector.